FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2020 Mar 6

PMID 32133359

Citations 123

Authors

Majid Mossahebi-Mohammadi

Meiyu Quan

Jin-San Zhang

Xiaokun Li

Affiliations

Soon will be listed here.

Abstract

Pluripotent stem cells (PSCs) isolated from embryonic stem cells (ESCs), induced PSC (iPSC) and also post-implantation epiblast-derived stem cells (EpiSCs) are known for their two unique characteristics: the ability to give rise to all somatic lineages and the self-renewal capacity. Numerous intrinsic signaling pathways contribute to the maintenance of the pluripotency state of stem cells by tightly controlling key transcriptional regulators of stemness including sex determining region Y box 2 (Sox-2), octamer-binding transcription factor (Oct)3/4, krueppel-like factor 4 (Klf-4), Nanog, and c-Myc. Signaling by fibroblast growth factor (FGF) is of critical importance in regulating stem cells pluripotency. The FGF family is comprised of 22 ligands that interact with four FGF receptors (FGFRs). FGF/FGFR signaling governs fundamental cellular processes such as cell survival, proliferation, migration, differentiation, embryonic development, organogenesis, tissue repair/regeneration, and metabolism. FGF signaling is mediated by the activation of RAS - mitogen-activated protein kinase (MAPK), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)-AKT, Phospholipase C Gamma (PLCγ), and signal transducers and activators of transcription (STAT), which intersects and synergizes with other signaling pathways such as Wnt, retinoic acid (RA) and transforming growth factor (TGF)-β signaling. In the current review, we summarize the role of FGF signaling in the maintenance of pluripotency state of stem cells through regulation of key transcriptional factors.

Citing Articles

Injective hydrogel encapsulating dental pulp stem cells for the treatment of traumatic optic nerve injury.

Luo L, Xing Z, Li Y, Wang B, Dong N, Sun J Front Bioeng Biotechnol. 2025; 13:1528749.

PMID: 40070549 PMC: 11893850. DOI: 10.3389/fbioe.2025.1528749.

aFGF gene-modified adipose-derived mesenchymal stem cells promote healing of full-thickness skin defects in diabetic rats.

Zhu Y, Chen P, Zhang Z, He X, Wang R, Fang Q Stem Cell Res Ther. 2025; 16(1):93.

PMID: 40001190 PMC: 11863861. DOI: 10.1186/s13287-025-04241-5.

Nanomaterial application for protein delivery in bone regeneration therapy.

Hariawan B, Miatmoko A, Anjani Q, Annuryanti F, Kamadjaja D, Nurkanto A Braz J Med Biol Res. 2025; 58:e14057.

PMID: 39907403 PMC: 11793153. DOI: 10.1590/1414-431X2024e14057.

Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study.

Cullell N, Caruana G, Elias-Mas A, Delgado-Sanchez A, Artero C, Buongiorno M Alzheimers Res Ther. 2025; 17(1):31.

PMID: 39891246 PMC: 11786353. DOI: 10.1186/s13195-024-01612-7.

Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review.

Narasimha R, Shreya S, Jayabal V, Yadav V, Rath P, Mishra B Vet Sci. 2025; 12(1).

PMID: 39852942 PMC: 11768649. DOI: 10.3390/vetsci12010067.

References

Vallier L, Alexander M, Pedersen R . Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci. 2005; 118(Pt 19):4495-509. DOI: 10.1242/jcs.02553. View

Evans M, Kaufman M . Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819):154-6. DOI: 10.1038/292154a0. View

Li M, Izpisua Belmonte J . Ground rules of the pluripotency gene regulatory network. Nat Rev Genet. 2017; 18(3):180-191. DOI: 10.1038/nrg.2016.156. View

Ding V, Ling L, Natarajan S, Yap M, Cool S, Choo A . FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling. J Cell Physiol. 2010; 225(2):417-28. DOI: 10.1002/jcp.22214. View

Zhang Y, Wang D, Xu J, Wang Y, Ma F, Li Z . Stat3 activation is critical for pluripotency maintenance. J Cell Physiol. 2018; 234(2):1044-1051. DOI: 10.1002/jcp.27241. View

Giulitti S, Pellegrini M, Zorzan I, Martini P, Gagliano O, Mutarelli M . Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics. Nat Cell Biol. 2019; 21(2):275-286. DOI: 10.1038/s41556-018-0254-5. View

Liu X, Nefzger C, Rossello F, Chen J, Knaupp A, Firas J . Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming. Nat Methods. 2017; 14(11):1055-1062. DOI: 10.1038/nmeth.4436. View

Gafni O, Weinberger L, AlFatah Mansour A, Manor Y, Chomsky E, Ben-Yosef D . Derivation of novel human ground state naive pluripotent stem cells. Nature. 2013; 504(7479):282-6. DOI: 10.1038/nature12745. View

Theunissen T, Powell B, Wang H, Mitalipova M, Faddah D, Reddy J . Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency. Cell Stem Cell. 2017; 15(4):524-526. PMC: 4534765. DOI: 10.1016/j.stem.2014.09.003. View

10.

Brons I, Smithers L, Trotter M, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes S . Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007; 448(7150):191-5. DOI: 10.1038/nature05950. View

11.

Cherepkova M, Sineva G, Pospelov V . Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death Dis. 2016; 7:e2050. PMC: 4816172. DOI: 10.1038/cddis.2015.387. View

12.

Rappolee D, Basilico C, Patel Y, Werb Z . Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development. 1994; 120(8):2259-69. DOI: 10.1242/dev.120.8.2259. View

13.

Li X . The FGF metabolic axis. Front Med. 2019; 13(5):511-530. PMC: 7102389. DOI: 10.1007/s11684-019-0711-y. View

14.

Davidson K, Mason E, Pera M . The pluripotent state in mouse and human. Development. 2015; 142(18):3090-9. DOI: 10.1242/dev.116061. View

15.

Greber B, Lehrach H, Adjaye J . Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells. 2006; 25(2):455-64. DOI: 10.1634/stemcells.2006-0476. View

16.

Lanner F, Rossant J . The role of FGF/Erk signaling in pluripotent cells. Development. 2010; 137(20):3351-60. DOI: 10.1242/dev.050146. View

17.

Chen G, Gulbranson D, Yu P, Hou Z, Thomson J . Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells. Stem Cells. 2012; 30(4):623-30. PMC: 3538808. DOI: 10.1002/stem.1021. View

18.

James D, Levine A, Besser D, Hemmati-Brivanlou A . TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development. 2005; 132(6):1273-82. DOI: 10.1242/dev.01706. View

19.

Mayshar Y, Rom E, Chumakov I, Kronman A, Yayon A, Benvenisty N . Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells. 2008; 26(3):767-74. DOI: 10.1634/stemcells.2007-1037. View

20.

Stavridis M, Lunn J, Collins B, Storey K . A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development. 2007; 134(16):2889-94. DOI: 10.1242/dev.02858. View